Two infrastructure dividend growth stocks that are remarkably well positioned to navigate the challenges. Read the full ...
Dogecoin did not follow the stock higher, with the meme token’s price down around 1.8% on the day, and retail sentiment on ...
Four competing technologies race to solve radiation therapy's 2.5% range problem. Deep dive into radiacoustic imaging, prompt ...
For the quarter, the Class I shares of Voya Intermediate Bond Fund outperformed its benchmark, Bloomberg US Aggregate Bond ...
Instagram’s algorithm in 2026 leans harder on a single early signal than most creators realize: how the profile’s existing ...
At a median 5-year (60.3 months) planned follow-up of the Phase 2b KEYNOTE-942/mRNA-4157-P201 study, intismeran ...
Harvard’s new grade cap is meant to curb a decade of rising A’s — but confidential course-level data shows the policy will ...
Moderna and Merck present 5-year data for intismeran autogene in combo with Keytruda in patients with high-risk stage III/IV melanoma following complete resection at 2026 ASCO mee ...
On January 5, 2026, the Company commenced its Normal Course Issuer Bid (" NCIB "). During Q1 2026, the Company repurchased and cancelled 227,600 common shares under the NCIB for total consideration of ...
Zacks Investment Research on MSN
NXP (NXPI) up 13.8% since last earnings report: Can it continue?
It has been about a month since the last earnings report for NXP Semiconductors (NXPI). Shares have added about 13.8% in that time frame, outperforming the S&P 500. Will the recent positive trend ...
According to Sina Finance, Covestro—a global leader in the chemical industry—recently announced that its MDI products across ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results